Exelixis | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Bayer EUR 6.19B 1.57B 2024-12
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Cytokinetics USD 938.22M 843.36M 2025-03
Eisai JPY 291.26B 22.65B 2024-12
Eli Lilly USD 3.09B 175.1M 2025-03
Exelixis USD 217.37M 40.97M 2025-01
Genmab DKK 9.86B 3.52B 2024-12
Glaxosmithkline GBP 3.87B 678M 2024-12
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 8.63B 4.61B 2025-03
Moderna USD 1.62B 304M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
Sanofi 7.44B 646M 2024-12
Takeda JPY 494.13B 364.89B 2024-12
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
Xencor USD 40.88M 11.84M 2024-12



Exelixis Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.